Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Wang Lihong, Che Xin, Guo Yongxue, Bian Yiying & Cheng Gang. (2014) Thermoresponsive ophthalmic poloxamer/tween/carbopol in situ gels of a poorly water-soluble drug fluconazole: preparation and in vitro–in vivo evaluation. Drug Development and Industrial Pharmacy 40:10, pages 1402-1410.
Read now
Read now
Mark A. Babizhayev, Anatoliy I. Deyev, Ekaterina L. Savel'Yeva, Vadim Z. Lankin & Yegor E. Yegorov. (2012) Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and skin aging. Journal of Dermatological Treatment 23:5, pages 345-384.
Read now
Read now
Alan R Hipkiss. (2009) Carnosine, diabetes and Alzheimer’s disease. Expert Review of Neurotherapeutics 9:5, pages 583-585.
Read now
Read now
Articles from other publishers (11)
Yaru Wang & Changhong Wang. (2022) Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye. Pharmaceutics 14:6, pages 1150.
Crossref
Crossref
Megha Barot, Mitesh Patel, Deep Kwatra & Ashim K. Mitra. 2013. Ocular Transporters and Receptors. Ocular Transporters and Receptors
229
248
.
Mark A. Babizhayev, Inna P. Khoroshilova-Maslova & Anne Kasus-Jacobi. (2012) Novel intraocular and systemic absorption drug delivery and efficacy of N-acetylcarnosine lubricant eye drops or carcinine biologics in pharmaceutical usage and therapeutic vision care. Fundamental & Clinical Pharmacology 26:5, pages 644-678.
Crossref
Crossref
Mark A. Babizhayev. (2011) Bioactivation antioxidant and transglycating properties of N‐acetylcarnosine autoinduction prodrug of a dipeptide L‐carnosine in mucoadhesive drug delivery eye‐drop formulation: powerful eye health application technique and therapeutic platform. Drug Testing and Analysis 4:6, pages 468-485.
Crossref
Crossref
Alan R. Hipkiss. (2011) Energy metabolism, proteotoxic stress and age-related dysfunction – Protection by carnosine. Molecular Aspects of Medicine 32:4-6, pages 267-278.
Crossref
Crossref
Mark A Babizhayev. (2010) Designation of imidazole-containing dipeptides as pharmacological chaperones. Human & Experimental Toxicology 30:7, pages 736-761.
Crossref
Crossref
Zhou TianyangZhu LingWang LiyaZhang Junjie. (2011) Ocular Pharmacokinetics of Carnosine 5% Eye Drops Following Topical Application in Rabbit. Journal of Ocular Pharmacology and Therapeutics 27:1, pages 93-97.
Crossref
Crossref
Deep Kwatra, Ravi Vaishya, Ripal Gaudana, Jwala Jwala & Ashim K. Mitra. 2010. Prodrugs and Targeted Delivery. Prodrugs and Targeted Delivery
181
205
.
Mark A Babizhayev. (2010) New Concept in Nutrition for the Maintenance of the Aging Eye Redox Regulation and Therapeutic Treatment of Cataract Disease; Synergism of Natural Antioxidant Imidazole-Containing Amino Acid-Based Compounds, Chaperone, and Glutathione Boosting Agents: A Systemic Perspective on Aging and Longevity Emerged From Studies in Humans. American Journal of Therapeutics 17:4, pages 373-389.
Crossref
Crossref
M.A. Babizhayev. (2009) Potentiation of Intraocular Absorption and Drug Metabolism of N-Acetylcarnosine Lubricant Eye Drops: Drug Interaction with Sight Threatening Lipid Peroxides in the Treatment for Age-Related Eye Diseases. Drug Metabolism and Drug Interactions 24:2-4.
Crossref
Crossref
Alan R. Hipkiss. 2009.
87
154
.